Acute respiratory infection, chronic inflammatory bronchitis
Code No. Origin Company Therapeutic INN Stage OTC/RX Target Country Information
Re-0014 Respiratory Ivy leaf & Coptis Rhizome Butanol extract Marketed RX -
ㆍProduct Description
ㆍGeneral Introduction
- Classification: Antitussive & Expectorant
- Ingredient and Strength: Coptis Rhizome Butanol Extract (87.5mg) & Ivy leaf 30% Ethanol dried Extract (262.5mg)
- Efficacy: Relievement of cough and sputum due to acute respiratory infection and chronic inflammatory bronchitis

  
ㆍMechanism of Action
ㆍIndication
Indicated for Acute respiratory infection and chronic inflammatory bronchitis
ㆍBusiness Type
This company is looking for its partner for the distribution worldwide
Name N/A Company N/A
Homepage N/A Department N/A
Title N/A E-mail N/A
Phone N/A Country N/A
back Inquire